Projected Growth of the Global Pediatric Vaccine Market to Reach $62.48 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric vaccine market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Pediatric Vaccine Market By The End Of 2029?

The pediatric vaccine market has experienced significant expansion in recent years. This market is set to increase from $44.2 billion in 2024 to $46.95 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.2%. The historical development of this market is largely due to factors such as the rising incidence of chronic diseases, the establishment of immunization policies designed to eliminate endemic diseases, and an increase in investment for vaccine creation.

The pediatric vaccine market is anticipated to demonstrate substantial expansion over the upcoming years. It is projected to achieve a valuation of $62.48 billion by 2029, progressing at a compound annual growth rate (CAGR) of 7.4%. This expected growth during the forecast period is attributable to several factors, including a rise in cases of invasive cervical cancer, a strong late-stage development pipeline alongside new drug approvals, and an increasing prevalence of infectious diseases. Significant trends identified for this period encompass the creation of combination vaccines to address market demands, a focus on investing in research and development activities for efficacious vaccine production, prioritizing the development of live attenuated vaccines, leveraging novel immune engineering and advanced delivery systems, and integrating artificial intelligence (AI) into vaccine development to streamline procedures and facilitate manufacturing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Business Drivers Are Underpinning The Growth Of The Pediatric Vaccine Market?

An increasing incidence of chronic illnesses such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below is anticipated to contribute to the growth of the pediatric vaccines market. Children and adolescents with chronic conditions face a growing risk of severe disease outcomes and complications from infectious diseases. In March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory body entrusted with gathering and evaluating data and providing factual recommendations, nearly half of the overall population (46.6%, or 11.6 million) had at least one chronic condition. This heightened prevalence of chronic diseases among children consequently boosts the demand for immunization against these conditions, thereby driving the growth of the pediatric vaccines market.

What Are The Principal Segment Types In The Pediatric Vaccine Market?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

How Are Industry Trends Steering The Expansion Of The Pediatric Vaccine Market?

The need for innovative vaccines is consistently increasing to provide better protection against complex infectious diseases, including tuberculosis and HIV/AIDS, as well as chronic non-communicable conditions like cancer and neurodegenerative disorders. Modern approaches to vaccine development incorporate structural immunogenic design, gene-based vaccine platforms, and powerful adjuvant recombinant antigen formulations. To satisfy the rising demand for new vaccines, pediatric vaccine manufacturers and developers are constantly seeking breakthroughs in vaccine design and production technologies. For instance, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced that the U.S. FDA had approved REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

Which Companies Are Contributing Significantly To The Pediatric Vaccine Market Growth?

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Region Offers The Most Opportunity For Pediatric Vaccine Market Expansion?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2025, By The Business Research Company

Hearing Aid Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearing-aid-devices-and-equipment-global-market-report

Hearing Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearing-implants-global-market-report

Anesthesia Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795